1. Introduction {#sec1-nutrients-11-01362}
===============

Hypertension is the major leading risk factor for atherosclerosis and several diseases, especially renal and cardiovascular disorders, including myocardial infarction, stroke, and heart failure \[[@B1-nutrients-11-01362]\]. Blood pressure is influenced by various genetic and lifestyle factors including nutrition \[[@B2-nutrients-11-01362]\]. In this regard, sodium is an important mineral which, besides its functions in fluid balance, action potential generation, digestive secretions and absorption of many nutrients, also plays an important role in blood pressure regulation with a reduced sodium intake being associated with a reduction in systolic and diastolic blood pressure \[[@B3-nutrients-11-01362]\]. Therefore, independent of body weight, sex and age, too much dietary salt (sodium chloride) is regarded as an established risk factor for hypertension \[[@B4-nutrients-11-01362]\]. Concomitant to sodium reduction, higher potassium intake or supplementation has also been repeatedly shown to reduce the blood pressure of especially hypertensive persons (reviewed in \[[@B5-nutrients-11-01362]\]). Therefore, the American Heart Association recently proposed a dietary potassium intake of 3500--5000 mg/day, in addition to the well-known advice to reduce the consumption of dietary sodium (\<1500 mg/day or at least 1000 mg/day decrement) for adults with normal and elevated blood pressure \[[@B6-nutrients-11-01362]\]. In addition, the WHO recommends that sodium consumption should be less than 2000 mg (5 g of salt) and potassium intake at least 3510 mg for adults per day \[[@B7-nutrients-11-01362]\].

In addition to the blood pressure lowering effects of sodium reduction or higher potassium intake also in several studies and meta-analyses calcium supplementation has been shown to exert beneficial effects on the risk for gestational hypertension \[[@B8-nutrients-11-01362],[@B9-nutrients-11-01362]\], especially in women with low dietary calcium intake.

Furthermore, from the electrolytes, magnesium is also effective in reducing blood pressure, especially by acting as a natural calcium channel blocker, increasing nitric oxide levels and improving endothelial dysfunction \[[@B10-nutrients-11-01362],[@B11-nutrients-11-01362]\].

Early studies from the 1980s suggest that also chloride has an independent effect on blood pressure (reviewed in \[[@B12-nutrients-11-01362]\]). In these studies it was shown that replacing chloride with bicarbonate, citrate or phosphate as the anion for sodium did not lead to increases in blood pressure in rats or humans compared to sodium chloride \[[@B13-nutrients-11-01362],[@B14-nutrients-11-01362],[@B15-nutrients-11-01362]\]. On the other hand, interestingly, lower serum chloride levels were associated with higher cardiovascular and all-cause mortality risk in epidemiological studies \[[@B16-nutrients-11-01362]\].

Sulphur enters the body primarily as a component of the amino acids cysteine and methionine, and, as a part of the gaseous signaling molecule hydrogen sulfide (H~2~S), it exerts antihypertensive effects in experimental models \[[@B17-nutrients-11-01362]\]. Also garlic, which contains several functional sulfur-containing components, has been consistently shown to exert blood pressure-lowering effects with an average of 8--9 mmHg in systolic blood pressure (SBP) and 6--7 mmHg in diastolic blood pressure (DBP) in hypertensive patients \[[@B18-nutrients-11-01362]\].

Dietary phosphorus has also been shown to be related to blood pressure \[[@B19-nutrients-11-01362]\]. For example, in the International Study of Macro and Micro-Nutrients and Blood Pressure (INTERMAP) it was shown that dietary phosphorus was inversely associated with blood pressure in a multiple regression model \[[@B20-nutrients-11-01362]\]. Also in 13,444 participants from the Atherosclerosis Risk in Communities cohort and the Multi-Ethnic Study of Atherosclerosis cohorts compared with individuals in the lowest quintile of phosphorus intake at baseline, those with the highest phosphorus intake showed lower systolic and diastolic blood pressures after adjustment for dietary and non-dietary confounders \[[@B21-nutrients-11-01362]\].

Hypertension remains a serious public health issue and found as one amongst the major risk factors, also including smoking, high blood glucose, and high body-mass index, all responsible for approximately 29 million deaths globally \[[@B22-nutrients-11-01362]\]. According to the World Heart Federation, hypertension is the most important risk factor for stroke which causes about 50% of ischaemic strokes \[[@B23-nutrients-11-01362]\]. Nutrition has an important impact on blood pressure with salt playing a prominent role. However, also especially potassium, in addition probably magnesium, and calcium, and possibly also chloride, sulphur and phosphorus exert at least some effects on blood pressure. Therefore, the objective of this review was to summarize meta-analyses studying the effect and associations of these electrolytes as supplements or diets on human blood pressure or risk for hypertension throughout the last years.

2. Materials and Methods {#sec2-nutrients-11-01362}
========================

This review summarizes meta-analyses of publications studying the effect or association between electrolytes and blood pressure. In this regard, we conducted a search in PubMed, Scopus, and Google scholar databases by entering the search terms "(hypertension or blood pressure) and (sodium or potassium or calcium or magnesium or chloride or sulphur or sulphate or phosphorus or phosphate or salt) and (meta-analysis or metaanalysis)". The literature search was conducted in June 2018 with a 10-year publication restriction in order to ensure more recent studies. Search results were limited to English language articles.

2.1. Eligibility Criteria {#sec2dot1-nutrients-11-01362}
-------------------------

Meta-analyses of randomized controlled trials or observational studies were included in this review. The availability of (mean) blood pressure reductions and/or relative risk estimates e.g., risk ratios, odds ratios, weighted mean difference and confidence intervals were a prerequisite for the inclusion of the meta-analyses. Reviews and summaries of meta-analyses, meta-analysis not including the primary outcome, (e.g., blood pressure reduction or hypertension risk), or meta-analysis with combined effects of two minerals were excluded.

The initial search revealed a total of 2182 articles ([Figure 1](#nutrients-11-01362-f001){ref-type="fig"}). After screening irrelevant, duplicate and other studies not meeting the inclusion criteria 32 meta-analyses were included in this review \[[@B8-nutrients-11-01362],[@B11-nutrients-11-01362],[@B24-nutrients-11-01362],[@B25-nutrients-11-01362],[@B26-nutrients-11-01362],[@B27-nutrients-11-01362],[@B28-nutrients-11-01362],[@B29-nutrients-11-01362],[@B30-nutrients-11-01362],[@B31-nutrients-11-01362],[@B32-nutrients-11-01362],[@B33-nutrients-11-01362],[@B34-nutrients-11-01362],[@B35-nutrients-11-01362],[@B36-nutrients-11-01362],[@B37-nutrients-11-01362],[@B38-nutrients-11-01362],[@B39-nutrients-11-01362],[@B40-nutrients-11-01362],[@B41-nutrients-11-01362],[@B42-nutrients-11-01362],[@B43-nutrients-11-01362],[@B44-nutrients-11-01362],[@B45-nutrients-11-01362],[@B46-nutrients-11-01362],[@B47-nutrients-11-01362],[@B48-nutrients-11-01362],[@B49-nutrients-11-01362],[@B50-nutrients-11-01362],[@B51-nutrients-11-01362],[@B52-nutrients-11-01362],[@B53-nutrients-11-01362]\].

2.2. Data Extraction {#sec2dot2-nutrients-11-01362}
--------------------

Two reviewers (C.E and N.K) independently extracted the information from the papers. A third reviewer (S.I) rechecked the data and discrepancies were resolved through consensus. Study outcomes with defined number of trials/participants, study type/aims, patient characteristics, average study duration, minerals dosage (diet/supplements) and dietary modification were extracted from the selected meta-analyses. Also (mean) change in systolic and diastolic blood pressure (SBP and DBP), or relative risks (RR), odds ratios or effect sizes with 95% CI were extracted as main outcomes measures from the papers.

3. Results {#sec3-nutrients-11-01362}
==========

We identified meta-analyses for sodium, potassium, calcium and magnesium. No meta-analyses were found for the electrolytes chloride, sulphur and phosphorus.

3.1. Effect of Dietary Sodium/Salt Intake/Reduction on Blood Pressure {#sec3dot1-nutrients-11-01362}
---------------------------------------------------------------------

Overall, fourteen meta-analyses of randomized control trials and observational studies analyzing the effect of sodium modification/reduction on blood pressure were selected \[[@B24-nutrients-11-01362],[@B25-nutrients-11-01362],[@B26-nutrients-11-01362],[@B27-nutrients-11-01362],[@B28-nutrients-11-01362],[@B29-nutrients-11-01362],[@B30-nutrients-11-01362],[@B31-nutrients-11-01362],[@B32-nutrients-11-01362],[@B33-nutrients-11-01362],[@B34-nutrients-11-01362],[@B35-nutrients-11-01362],[@B36-nutrients-11-01362],[@B37-nutrients-11-01362]\].

The meta-analyses of randomized controlled studies (*n* = 12) included 5--177 numbers of trials with 12 to 23,858 participants ([Table 1](#nutrients-11-01362-t001){ref-type="table"}). The duration of trials varied between 4 days to 71 months with sodium intake being reduced from 1.2 to 5.7 g/day (52--250 mmol/day) and salt reduction was 2 to 9.6 g/day (34−164 mmol/day). The results showed that blood pressure lowering effects ranged from −0.7 (95% confidence interval: −2.6 to 1.2) mmHg for lowest and −8.9 (−14.1 to −3.7) mmHg for highest SBP reduction, respectively, while lowest to highest reduction for DBP was between 0.03 (−0.4 to 0.4) to −5.9 (−9.7 to −2.1) mmHg.

Moreover, two meta-analyses included observational studies, including 10--18 trials with 8093--134,916 participants. The observational study of Talukder et al. \[[@B36-nutrients-11-01362]\] observed a mean difference in blood pressure of 0.1 (−0.2 to 0.3) mmHg for SBP and 0.2 (0.1 to 0.4) mmHg for DBP with exposure of 4--405 mg/L water sodium levels. Subasinghe et al. \[[@B37-nutrients-11-01362]\] showed effect sizes of 1.36 (1.24 to 1.48) and 1.28 (1.13 to 1.45) for high salt exposure (6.9 to 42.3 g/day) on hypertension risk in rural and urban populations of low-and-middle income countries, respectively.

3.2. Effect of Potassium Supplementation on Blood Pressure {#sec3dot2-nutrients-11-01362}
----------------------------------------------------------

Five meta-analyses of randomized controlled trials evaluated the effect of oral potassium supplements on blood pressure \[[@B38-nutrients-11-01362],[@B39-nutrients-11-01362],[@B40-nutrients-11-01362],[@B41-nutrients-11-01362],[@B42-nutrients-11-01362]\]. The meta-analyses included 10--33 trials and 556--1892 participants ([Table 2](#nutrients-11-01362-t002){ref-type="table"}). Oral potassium dosages in the supplements were between 6 and 250 mmol/day (0.23--9.7 g/day) with study durations of 4--52 weeks. The lowest to highest reduction in blood pressure was between --3.5 (95% confidence interval: −5.2 to −1.8) to −9.5 (−10.8 to −8.1) mmHg for SBP and −2 (−3.1 to −0.9) to −6.4 (−7.3 to −5.6) mmHg for DBP. In addition, potassium was found to be especially effective in in reducing blood pressure of high sodium consumers.

3.3. Calcium Intake in Form of Supplements or Diets and Risk for Gestational Hypertension or Blood Pressure Lowering {#sec3dot3-nutrients-11-01362}
--------------------------------------------------------------------------------------------------------------------

We identified six meta-analyses which evaluated the association of dietary calcium intake on the risk for gestational hypertension \[[@B8-nutrients-11-01362],[@B43-nutrients-11-01362],[@B44-nutrients-11-01362],[@B45-nutrients-11-01362]\] or the effect on blood pressure \[[@B46-nutrients-11-01362],[@B47-nutrients-11-01362]\]. Five meta-analyses of randomized controlled trials with a range of 4--16 trials and 2947--36,806 participants were included. The follow up intervention period was between 8 weeks to 7 years and the calcium intake was found to be between 0.5 g/day to 2 g/day. The results showed RR ranging from 0.55 to 0.91 for gestational hypertension while, the meta-analysis of Cormick et al., \[[@B47-nutrients-11-01362]\] found a mean difference of −1.4 (95% confidence interval: −2.2 to −0.7) mmHg for SBP and −1 (−1.5 to −0.5) mmHg for DBP reduction in normotensive people.

Furthermore, we found one meta-analysis including 16 observational trials of 757--41,214 pregnant women showing a lower OR for gestational hypertension \[OR: 0.63 (95% CI = 0.41--0.97)\] for highest versus lowest category of calcium intake \[[@B45-nutrients-11-01362]\].

Most of the meta-analyses showed that calcium supplements were associated with a reduced risk of gestational hypertension ([Table 3](#nutrients-11-01362-t003){ref-type="table"}). Besides, based on the results from the meta-analysis of Wu and Sun \[[@B46-nutrients-11-01362]\] calcium plus vitamin D supplementation non-significantly slightly increased SBP with no effects on DBP.

3.4. Effect of Magnesium on Blood Pressure or Hypertension Risk {#sec3dot4-nutrients-11-01362}
---------------------------------------------------------------

Eight meta-analyses of randomized control trials (*n* = 5) and observational studies (*n* = 3) were included to summarize the effects of magnesium on blood pressure or association with hypertension risk, respectively \[[@B11-nutrients-11-01362],[@B45-nutrients-11-01362],[@B48-nutrients-11-01362],[@B49-nutrients-11-01362],[@B50-nutrients-11-01362],[@B51-nutrients-11-01362],[@B52-nutrients-11-01362],[@B53-nutrients-11-01362]\] The randomized control trials included 7--28 number trials with 135--1694 of participants with the trial durations varying between 3--24 weeks. Magnesium intake ranged between 120--1006 mg/day. The summary showed SBP reductions in the range of −0.2 (95% confidence interval: −0.4 to −0.03) mmHg and −18.7 (−22.5 to −15.0) mmHg, and DBP reductions between −0.3 (−0.5 to −0.03) and −10.9 (−13.1 to −8.7) mmHg ([Table 4](#nutrients-11-01362-t004){ref-type="table"}). However, the meta-analysis of Rosanoff and Plesset (2013) \[[@B51-nutrients-11-01362]\], which showed the largest effects, only included a small sample of treated hypertensive patients, which probably responded highly to magnesium. When omitting this meta-analysis, the blood pressure lowering effects of magnesium would switch to a rather low to moderate level.

Moreover, observational studies showed a lower risk for hypertension with increasing magnesium intake \[[@B52-nutrients-11-01362]\] or higher circulating magnesium levels \[[@B53-nutrients-11-01362]\], respectively.

4. Discussion {#sec4-nutrients-11-01362}
=============

The major findings of this review were especially that sodium (salt) reduction and a higher intake of potassium have convincing blood pressure lowering effects. In addition, higher magnesium intake is suggested to possibly reduce blood pressure, especially in patients with hypertension. Moreover, sufficient calcium intake confers a protective effect regarding the risk for gestational hypertension.

There are several mechanistical explanations for the association between high sodium intake and blood pressure like enhanced reabsorption and retention of filtered sodium through the renal tubules \[[@B54-nutrients-11-01362]\], or activation of the brain renin--angiotensin--aldosterone system (RAAS), which is suggested to increase blood pressure through angiotensin II and aldosterone promoting locally oxidative stress and activating the sympathetic nervous system \[[@B55-nutrients-11-01362]\]. Furthermore, based on the "vasodysfunction theory" of salt induced hypertension, salt loading results in subnormal decreases in systemic vascular resistance leading to an increase in blood pressure \[[@B56-nutrients-11-01362]\]. In this regard salt sensitivity, which varies among individuals, is suggested to play an important role \[[@B3-nutrients-11-01362],[@B55-nutrients-11-01362]\].

In addition to blood pressure, in a recent systematic review and meta-analysis of randomized controlled trials it was analyzed that restriction of dietary sodium intake can reduce arterial stiffness, as expressed by carotid-femoral pulse wave velocity \[[@B57-nutrients-11-01362]\].

In addition to sodium modification, several studies and meta-analysis showed that potassium supplements reduce blood pressure and also the risk of hypertension \[[@B58-nutrients-11-01362]\]. Suggested mechanisms of the blood pressure lowering effects of potassium are (reviewed in \[[@B5-nutrients-11-01362]\]): improvement of endothelial function and NO release, vasodilatation by lowering cytosolic smooth muscle cell calcium, increasing natriuresis, and lowering the activity of the sympathetic nervous system. Furthermore the supportive blood pressure reducing effects of sodium modification in combination with potassium is well-documented \[[@B59-nutrients-11-01362]\].

Besides the interdependent effect of sodium and potassium, calcium and magnesium have also been implicated in the regulation of blood pressure \[[@B60-nutrients-11-01362]\]. Based on our results, magnesium showed a moderate blood pressure reducing effect in general, while the effects of calcium were primarily restricted to the prevention of gestational hypertension. The potential antihypertensive effects of magnesium are for example suggested to be related to calcium channel blockage, increases in nitric oxide, and better endothelial function \[[@B10-nutrients-11-01362]\]. In vascular smooth muscle cells, magnesium antagonizes Ca^2+^ by inhibiting transmembrane calcium transport and calcium entry with low magnesium levels causing an increase in intracellular free Ca^2+^ concentration and subsequently vascular contraction \[[@B61-nutrients-11-01362]\].

On the other hand, low dietary calcium intake is shown to be a risk factor for the development of hypertension especially for women with a history of gestational hypertension \[[@B62-nutrients-11-01362]\]. In this regard the World Health Organization recommends daily calcium supplementation of 1.5--2.0 g oral elemental calcium for pregnant women in populations with low dietary calcium intake to reduce the risk of pre-eclampsia and related complications \[[@B63-nutrients-11-01362]\].

Lifestyle modifications including weight loss, exercise, and healthy diets are proved to be important predictors to lower blood pressure or the risk for hypertension, respectively. For example, the Canadian hypertension education program guidelines (2016) proposed health behavior management for the prevention of hypertension such as physical exercise, weight management, limited alcohol consumption, stress management, reduce sodium intake and recommended dietary modification as the preferred method of increasing potassium intake (in patients who are not at risk of hyperkalemia) to get additional nutritional benefits of whole foods over prescribed supplements \[[@B64-nutrients-11-01362]\]. Similarly, the study findings of a systematic review and meta-analysis of randomized control trials showed that healthy dietary patterns including the dietary approaches to stop hypertension (DASH) diet, Nordic diet, and Mediterranean diet significantly lowered systolic and diastolic blood pressure \[[@B65-nutrients-11-01362]\].

5. Conclusions and Future Perspectives {#sec5-nutrients-11-01362}
======================================

Our brief exploration of meta-analyses showed that lowering sodium and increasing potassium intake would exert convincing blood pressure lowering effects, especially in hypertensive patients. The maximum extent of systolic blood pressure lowering was approximately in the order of 8 to 9 mmHg, which roughly equals a monotherapy with an antihypertensive drug \[[@B66-nutrients-11-01362]\]. This reflects the significant importance of healthy nutrition, in this case salt reduction and increase of dietary potassium intake, on blood pressure. Our summary of meta-analytic reviews also suggests that higher magnesium intake may exert beneficial effects on blood pressure, although the results were rather moderate. However, in some (treated) hypertensive patients ("high-responders") higher magnesium intake might result in larger effects. So, increasing/optimizing dietary magnesium intake could also be a helpful recommendation in patients with hypertension. Furthermore, there is convincing evidence that increasing/optimizing calcium intake can lower the risk for gestational hypertension, especially in women with initial low calcium intake.

We did not find any meta-analyses summarizing the effects of chloride, phosphorus and sulphur on blood pressure or hypertension risk. In general, few studies are available, which assessed the effect of these electrolytes on blood pressure. There are indications from observational studies that there might be some effects, however robust evidence is missing. For example, a very recent systematic review from McClure et al. (2019) did not detected a consistent association between total dietary phosphorus intake and blood pressure \[[@B67-nutrients-11-01362]\].

Relating to earlier studies replacing the chloride component of salt with other anions like bicarbonate or citrate might be a certain strategy, which could not only beneficially affect blood pressure but could show co-benefits regarding a (western) diet induced metabolic acid load \[[@B68-nutrients-11-01362]\]. Obviously, randomized (controlled) trials are necessary to study this assumption. Also, future clinical trials could determine the effect of different electrolytes on blood pressure by patients' self-assessment of blood pressure with new validated mHealth devices, like a previous study in obese individuals has shown \[[@B69-nutrients-11-01362]\].
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nutrients-11-01362-t001_Table 1

###### 

Effect of dietary sodium/salt reduction on blood pressure: A summary of meta-analyses of randomized (controlled) trials or observational studies.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                              No. of Trials   Study Characteristics                             No. of Participants                Patient Characteristics                                                                     Duration of Trials                                                                Sodium/Salt Intake or Reduction                                                   Blood Pressure Lowering in mmHg (95% CI)                                                                           Further Remarks/Summary
  -------------------------------------------------------- --------------- ------------------------------------------------- ---------------------------------- ------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aburto et al., 2013a \[[@B24-nutrients-11-01362]\]       36              Randomized controlled trials                      6736                               2273 (hypertensive)                                                                         Most studies (*n* = 31) \<3 months                                                Different reductions in sodium intake\                                            SBP: −3.4 (−4.3 to −2.5)\                                                                                          Reduced sodium intake decreases blood pressure in people both with and without hypertension.\
                                                                                                                                                                                                                                                                                                                                              Relative sodium reduction in the intervention group: ≥1/3 of control              DBP: −1.5 (−2.1 to −1.0)                                                                                           The reduction in blood pressure was greater in those with hypertension.

  Adler et al., 2014 \[[@B25-nutrients-11-01362]\]         6 (SBP)\        Randomized controlled trials                      3362 (SBP)\                        SBP (end of trial):\                                                                        7--36 months                                                                      Sodium intake: 70 to \>100 mmol/day                                               Normotensive:\                                                                                                     Normotensive persons: small blood pressure reduction.\
                                                           5 (DBP)                                                           2754 (DBP)                         (normotensive) 2079\                                                                                                                                                                                                                                            SBP: −1.2 (−2.3 to 0.02)\                                                                                          Hypertensive patients: greater reduction in SBP, no difference in DBP.
                                                                                                                                                                (hypertensive) 1283\                                                                                                                                                                                                                                            DBP: −0.8 (−1.4 to −0.2)\                                                                                          
                                                                                                                                                                DBP (end of trial):\                                                                                                                                                                                                                                            Hypertensive:\                                                                                                     
                                                                                                                                                                (normotensive) 2079\                                                                                                                                                                                                                                            SBP: −4.1 (−5.8 to −2.4)\                                                                                          
                                                                                                                                                                (hypertensive) 675                                                                                                                                                                                                                                              DBP: −3.7 (−8.4 to 0.9)                                                                                            

  Graudal et al., 2015 \[[@B26-nutrients-11-01362]\]       15              Randomized controlled trials                      12--114                            "time to maximal efficacy" analysis\                                                        1 to 6 weeks                                                                      Sodium reduction range: 55--118 mmol/day                                          No significant differences in SBP or DBP after initiation of salt reduction between week 1 and subsequent weeks.   Time dependent effects of salt reduction on blood pressure.\
                                                                                                                                                                7 studies with hypertensive patients\                                                                                                                                                                                                                                                                                                                                              The effect of salt reduction on blood pressure appears to reach maximal efficacy at 1 week and remain stable over subsequent time intervals.
                                                                                                                                                                7 studies with normotensive persons\                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                1 study hypertensive + normotensive                                                                                                                                                                                                                                                                                                                                                

  Graudal and Jürgens 2015 \[[@B27-nutrients-11-01362]\]   92              Randomized controlled trials                      661 Asians\                        9 Asian/9 Black/74 White population                                                         7--365 days                                                                       Sodium reduction: 63--103 mmol                                                    SBP: −3.2 (−4.0 to −2.5) (in Whites)\                                                                              SBP: no differences in ethnic groups.\
                                                                                                                             561 Blacks\                                                                                                                                                                                                                                                                                        −4.7 (−7.1 to −2.3) (in Blacks)\                                                                                   DBP: small differences between black and white people.
                                                                                                                             3782 Whites                                                                                                                                                                                                                                                                                        −3.8 (−6.4 to −1.3) (in Asians)\                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP:−1.5 (−2.1 to −1.0) (in Whites)\                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                −3.0 (−4.0 to −2.0) (in Blacks)\                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                −2.0 (−3.0 to −0.9) (in Asians)                                                                                    

  Gay et al., 2016 \[[@B28-nutrients-11-01362]\]           24              Randomized controlled trials                      23,858                             11 to 2570 participants (median: 129)\                                                      Trial durations ranged from 6 to 48 months of follow−up (median: 12 months)       Dietary interventions (including low sodium diets)                                Overall pooled net effect of diets:\                                                                               This meta-analysis shows that dietary interventions (including low sodium diets) provide clinically significant net blood pressure reductions, and that some dietary patterns may be more effective than others.
                                                                                                                                                                participants \>19 years old                                                                                                                                                                                                                                     SBP: −3.1 (−3.9 to −2.3) DBP: −1.8 (−2.2 to −1.4)                                                                  

  Graudal et al., 2017 \[[@B29-nutrients-11-01362]\]       177             Randomized controlled trials                      12,210                             White people with hypertension.\                                                            4--1100 days                                                                      Mean sodium reduction: 135 mmol/day\                                              Hypertensive (White):\                                                                                             High-quality evidence for White people; moderate-quality evidence for Black/Asian people
                                                                                                                                                                (84 studies; 5925 participants in SBP; 85 studies; 6001 participants in DBP)\                                                                                                 range; \<100 to ≥250 mmol/day                                                     SBP: −5.5 (−6.5 to −4.6)\                                                                                          
                                                                                                                                                                Black people with hypertension.\                                                                                                                                                                                                                                DBP: −2.9 (−3.4 to −2.3)\                                                                                          
                                                                                                                                                                (8 studies; 619 participants in SBP and DBP)\                                                                                                                                                                                                                   Hypertensive (Black):\                                                                                             
                                                                                                                                                                Asian people with hypertension.\                                                                                                                                                                                                                                SBP: −6.6 (−9.0 to −4.2)\                                                                                          
                                                                                                                                                                (8 studies; 501 participants in SBP and DBP)\                                                                                                                                                                                                                   DBP: −2.9 (−4.5 to −1.30)\                                                                                         
                                                                                                                                                                White people with normotension.\                                                                                                                                                                                                                                Hypertensive (Asian):\                                                                                             
                                                                                                                                                                (89 studies, 8569 participants in SBP; 90 studies, 8833 participants in DBP)\                                                                                                                                                                                   SBP: −7.8 (−11.4 to −4.1)\                                                                                         
                                                                                                                                                                Black people with normotension.\                                                                                                                                                                                                                                DBP: −2.7 (−4.2 to −1.2)\                                                                                          
                                                                                                                                                                (7 studies, 506 participants in SBP and DBP)\                                                                                                                                                                                                                   Normotensive (White):\                                                                                             
                                                                                                                                                                Asian people with normotension.\                                                                                                                                                                                                                                SBP: −1.1 (−1.6 to −0.6)\                                                                                          
                                                                                                                                                                (3 studies, 393 participants in SBP and DBP)                                                                                                                                                                                                                    DBP: 0.03 (−0.4 to 0.4)\                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                Normotensive (Black)\                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                SBP: −4.0 (−7.4 to −0.7)\                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −2.0 (−4.4 to 0.4)\                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                Normotensive (Asian):\                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                SBP: −0.7 (−3.9 to 2.4)\                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −1.6 (−3.4 to 0.1)                                                                                            

  He et al., 2013 \[[@B30-nutrients-11-01362]\]            34              Randomized trials                                 3230                               990 (of 22 trials) hypertensive\                                                            Median duration: 5 weeks in hypertensive people, 4 weeks in normotensive people   Salt reduction: 75 mmol/day (4.4 g/day).\                                         Total SBP: −4.2 (−5.2 to −3.2)\                                                                                    Reduction in SBP was significant in both black and white people and in women and men.\
                                                                                                                                                                2240 (of 12 trials) normotensive                                                                                                                                              Reduction of urinary sodium: 40--120 mmol/day (2.3--7.0 g/day).                   DBP: −2.1 (−2.7 to −1.5)\                                                                                          Significant effects on blood pressure were seen in hypertensives and normotensives.\
                                                                                                                                                                                                                                                                                                                                                                                                                                Hypertensive: SBP: −5.4 (−6.6 to −4.2)\                                                                            Dose-response relation: the greater the reduction in salt intake, the greater the fall in blood pressure.
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −2.8 (−3.5 to −2.1)\                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                Normotensive: SBP: −2.4 (−3.6 to −1.3)\                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −1.0 (−1.9 to −0.2)                                                                                           

  He and MacGregor 2011 \[[@B31-nutrients-11-01362]\]      6               Outcome trials                                    6250                               3 trials in normotensive participants\                                                      6--36 months                                                                      Salt reduction: 2--2.3 g/day                                                      Normotensive:\                                                                                                     Significant reduction in cardiovascular events
                                                                                                                                                                3 trials in hypertensive patients                                                                                                                                                                                                                               SBP: −1.1 (−0.1 to 2.3)\                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −0.8 (0.2 to 1.4)\                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                Hypertensive:\                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                SBP: −4.1 (2.4 to 5.8)\                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −3.7 (−0.9 to 8.4)                                                                                            

  Kelly et al., 2016 \[[@B32-nutrients-11-01362]\]         5               Randomized and non-randomized controlled trials   1214                               Normotensive participants (≥18 years) with SBP ≤140 mmHg                                    4 weeks to 48 months                                                              Salt reduction: −75 mmol/day (range; −37 to −136 mmol).                           SBP: −0.7 (−2.6 to 1.2)\                                                                                           No significant change in SBP or DBP following reduction of dietary sodium over the period of 4 weeks to 36 months
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −0.6 (−1.3 to 0.1)                                                                                            

  Peng et al., 2014 \[[@B33-nutrients-11-01362]\]          5               Randomized controlled trials                      1974                               Hypertensive and normotensive participants                                                  6 months to 2 years                                                               Different salt substitutes vs. common salt (NaCl).                                SBP: −4.9 (−7.3 to −2.5)\                                                                                          Salt substitutes significantly reduced both SBP and DBP
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −1.5 (−2.7 to −0.3)                                                                                           

  Taylor et al., 2011 \[[@B34-nutrients-11-01362]\]        7               Randomized controlled trials                      3 trials normotensive (3518),\     Adults ≥18 years, irrespective of gender/ethnicity.\                                        Trials follow-up ranged\                                                          Salt reduction; \<70--100 mmol/ day.\                                             Normotensives (mean difference)\                                                                                   Significant reduction of SBP in hypertensive patients
                                                                                                                             2 trials hypertensive (758),\      Studies of children/pregnant women were excluded.                                           6 to 71 months                                                                    Urinary 24-h sodium excretion:\                                                   SBP:−1.1 (−2.3 to 0.1)\                                                                                            
                                                                                                                             1 trial mixed pop. (1981),\                                                                                                                                                                                      Normotensive (mean diff.):\                                                       DBP:−0.8 (−1.4 to −0.2)\                                                                                           
                                                                                                                             1 trial with heart failure (234)                                                                                                                                                                                 34.2 mmol/24 h (18.8--49.6),\                                                     Hypertensives\                                                                                                     
                                                                                                                                                                                                                                                                                                                                              Hypertensive (mean diff.):\                                                       SBP: −4.1 (−5.8 to −2.4)\                                                                                          
                                                                                                                                                                                                                                                                                                                                              39.1 mmol/24 h (31.1--47.1)                                                       DBP: −3.7 (−8.4 to 0.9)                                                                                            

  Wang et al., 2015 \[[@B35-nutrients-11-01362]\]          6               Interventional studies                            3153                               Chinese adults aged ≥35 years                                                               At most 1 week                                                                    Salt level reduced in hypertensive patients: 9.6 g/day (163.0 mmol/day sodium).   Normotensive + hypertensive:\                                                                                      Salt restriction lowers mean BP in Chinese adults, with the strongest effect among hypertensive participants.
                                                                                                                                                                                                                                                                                                                                                                                                                                SBP: −6.3 (−7.2 to −5.4)\                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −3.2 (−3.7 to −2.7)\                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                Hypertensive:\                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                SBP: −8.9 (−14.1 to −3.7)\                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: −5.9 (−9.7 to −2.1)                                                                                           

  **Observational Studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Talukder et al., 2017 \[[@B36-nutrients-11-01362]\]      10              Observational studies                             8093                               7 studies (12 datasets) with 3747 participants with low/high water sodium exposure groups                                                                                     4--405 mg/L water sodium level                                                    Standardized mean difference:\                                                                                     An (inconclusive) association between water sodium and human blood pressure is suggested, more consistently for DBP.
                                                                                                                                                                                                                                                                                                                                                                                                                                SBP: 0.1 (−0.2 to 0.3)\                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                DBP: 0.2 (0.1 to 0.4)                                                                                              

  Subasinghe et al., 2016 \[[@B37-nutrients-11-01362]\]    18              Observational studies                             134,916                            Participants in urban and rural areas in low-and-middle income countries\                                                                                                     Daily salt intake range: 6.9 to 42.3 g/day                                        Effect size (ES) of hypertension\                                                                                  Excessive salt intake has a greater impact on the prevalence of hypertension in urban than rural regions.
                                                                                                                                                                (LMICs).\                                                                                                                                                                                                                                                       ES 1.36 (1.24 to 1.48)\                                                                                            
                                                                                                                                                                Age: 24--65.                                                                                                                                                                                                                                                    ES 1.28 (1.13 to 1.45)                                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SBP = Systolic blood pressure; DBP = Diastolic blood pressure.

nutrients-11-01362-t002_Table 2

###### 

Effect of potassium supplementation on blood pressure: A summary of meta-analyses of randomized controlled trials.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                              No. of trials   Study Characteristic                    No. of Participants   Patient Characteristics                                       Duration of Trials      Potassium Dosage (Supplements)                              Blood Pressure Lowering in mmHg (95%CI)   Further Remarks/Summary
  -------------------------------------------------------- --------------- --------------------------------------- --------------------- ------------------------------------------------------------- ----------------------- ----------------------------------------------------------- ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aburto et al., 2013b \[[@B38-nutrients-11-01362]\]       21              Randomized controlled trials            1892/1857             Hypertensive\                                                 \<2 to \>4 months       \<90 mmol/day to \>155 mmol/day in the intervention group   SBP: −3.5 (−5.2 to −1.8)\                 Effect seen in people with hypertension but not in those without hypertension.\
                                                                                                                                         818(SBP)/828(DBP)                                                                                                                                 DBP: −2.0 (−3.1 to −0.9)                  Intake above 120 mmol/day did not seem to have any additional benefit.\
                                                                                                                                                                                                                                                                                                                                     Potassium may be more effective in reducing blood pressure at higher levels of sodium consumption.

  Binia et al., 2015 \[[@B39-nutrients-11-01362]\]         15              Randomized controlled trials            917                   400 hypertensives\                                            4--24 weeks             \<40--120 mmol/day                                          All:\                                     Potassium supplementation is associated with reduction of blood pressure in patients who are not on antihypertensive medication, and the effect is significant in hypertensive patients.
                                                                                                                                         329 normotensives\                                                                                                                                SBP: −4.7 (−7.0 to −2.4)\                 
                                                                                                                                         188 hypertensive or normotensive persons (mixed population)                                                                                       DBP: −3.5 (−5.7 to −1.3)\                 
                                                                                                                                                                                                                                                                                           Hypertensive patients:\                   
                                                                                                                                                                                                                                                                                           SBP: −6.8 (−9.3 to −4.3)\                 
                                                                                                                                                                                                                                                                                           DBP: −4.7 (−7.5 to −1.8)                  

  Filippini et al., 2017 \[[@B40-nutrients-11-01362]\]     33              Randomized controlled trials            1829                  1163 (studies ≥4 weeks overall)                               \<4 to ≥12 weeks        25--250 mmol/day                                            SBP: −4.5 (−5.9 to −3.1)\                 Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers.
                                                                                                                                                                                                                                                                                           DBP: −3.0 (−4.8 to −1.1)                  

  Poorolajal et al., 2017 \[[@B41-nutrients-11-01362]\]    23              Randomized controlled trials            1213                  Primary hypertension:\                                        4--52 weeks             6--200 mmol/day                                             SBP: −4.3 (−6.0 to −2.5)\                 Potassium supplementation has a modest but significant impact on blood pressure.
                                                                                                                                         732 (SBP)\                                                                                                                                        DBP: −2.5 (−4.1 to −1.0)                  
                                                                                                                                         695 (DBP)                                                                                                                                                                                   

  Bommel and Cleophas 2012 \[[@B42-nutrients-11-01362]\]   10              Crossover and parallel design studies   556                   High salt intake, \>170 mmol/24h                              Follow up 8--16 weeks   Not available                                               SBP: −9.5 (−10.8 to −8.1)\                Potassium treatment reduces considerably the blood pressure of hypertensive patients on salt rich diets.
                                                                                                                                                                                                                                                                                           DBP: −6.4 (−7.3 to −5.6)                  
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SBP = Systolic blood pressure; DBP = Diastolic blood pressure.

nutrients-11-01362-t003_Table 3

###### 

Calcium intake in form of diets or supplements and risk for gestational hypertension or effect on blood pressure: a summary of meta-analyses of randomized controlled trials or observational studies.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                             No. of Trials   Study Characteristic           No. of Participants                                   Study Aims                                                                                                                                                                  Duration of Trials                                                                                                   Calcium Dosage (Diet or Supplement)                                                     Blood Pressure Lowering in mmHg or RR/OR for Gestational Hypertension (95% CI)   Further Remarks/Summary
  ------------------------------------------------------- --------------- ------------------------------ ----------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Imdad et al., 2011 \[[@B8-nutrients-11-01362]\]         6               Randomized controlled trials   Calcium-group:\                                       Effect of calcium supplementation on gestational hypertensive disorders in studies from developing countries                                                                Calcium supplements in all the included studies were before 20--32 weeks of gestation and continued till delivery.   0.5--2 g/day                                                                            RR: 0.55 (0.36 to 0.85)                                                          Calcium supplementation during pregnancy was associated with a significant reduced risk of acquiring gestational hypertension.
                                                                                                         4919\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                         Control group:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                         4942                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Hofmeyr et al., 2014 \[[@B43-nutrients-11-01362]\]      12 trials       Randomized controlled trials   15,470 women                                          Assessing the effects of calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child outcomes                            Calcium supplementation started at the latest from 34 weeks of pregnancy.                                            High-dose calcium supplementation (≥1 g/day)                                            RR: 0.65 (0.53 to 0.81)                                                          Average risk of high blood pressure was reduced with calcium supplementation compared with placebo.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         There was also a reduction in hypertension with low-dose calcium supplementation (\<1 g/day).

  An et al., 2015 \[[@B44-nutrients-11-01362]\]           4               Randomized controlled trials   Gestational hypertension: 7252\                       Assessing the effectiveness of calcium supplementation during pregnancy on reducing the risk of hypertensive disorders of pregnancy and related problems.                   From \~11--24 weeks of pregnancy to delivery                                                                         Supplementation with calcium (at least \>1 g/day)                                       Gestational hypertension:\                                                       Calcium supplementation appears to reduce the risk of hypertension in pregnancy.\
                                                                                                         Control group: 7272\                                                                                                                                                                                                                                                                                                                                                                                                                           RR: 0.91 (0.84 to 0.99)\                                                         No significant reduction in the risk of severe gestational hypertension.
                                                                                                         Severe gestational hypertension: 6673\                                                                                                                                                                                                                                                                                                                                                                                                         Severe gestational hypertension:\                                                
                                                                                                         Control group: 6684                                                                                                                                                                                                                                                                                                                                                                                                                            RR: 0.81 (0.60 to 1.09)                                                          

  Wu and Sun 2017 \[[@B46-nutrients-11-01362]\]           8               Randomized controlled trials   36,806                                                Evaluation the effect of calcium plus vitamin-D (CaD) supplements on the changes in BP from baseline to the longest follow-up time point in male and female participants.   8 weeks to 7 years                                                                                                   Intervention dose of calcium (≤1000 mg/day, 5 trials or \>1000 mg/day, 3 trials)        Mean differences in SBP: 0.6 (−1 to 2.20)\                                       Calcium plus vitamin D supplementation slightly increased SBP, but the difference was not statistically significant.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Mean differences in DBP: −0.2 (−0.9 to 0.5)                                      Calcium plus vitamin D supplementation did not significantly affected DBP reduction.

  Cormick et al., 2015 \[[@B47-nutrients-11-01362]\]      16              Randomized controlled trials   SBP: 3048 (16 studies)\                               Assessing the efficacy and safety of calcium supplementation versus placebo or control for reducing blood pressure in normotensive people                                   Median follow up intervention period of 3.5 months                                                                   For most studies the intervention was 1000 mg to 2000 mg of elemental calcium per day   Mean difference:\                                                                The quality of evidence was high for doses of calcium of 1000 to 1500 mg/day and was moderate for lower or higher doses.\
                                                                                                         DBP: 2947 (15 studies)                                                                                                                                                                                                                                                                                                                                                                                                                         SBP: −1.4 (−2.2 to −0.7)\                                                        Calcium intake slightly reduced both SBP and DBP in normotensive people.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        DBP: −1 (−1.5 to −0.5)                                                           

  **Observational studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Schoenaker et al., 2014 \[[@B45-nutrients-11-01362]\]   16              Observational studies          Case-control studies:\                                Assessing the effect of dietary factors on hypertensive disorders during pregnancy (gestational hypertension and pre-eclampsia)                                                                                                                                                                  Highest group \>1600 mg/day versus lowest group \<1000 mg/day                           Gestational hypertension (comparing highest to lowest):\                         Results from case--control studies consistently showed lower reported calcium intake for pregnant women with hypertensive disorders (gestational hypertension and preeclampsia)
                                                                                                         757 pregnant women\                                                                                                                                                                                                                                                                                                                                                                                                                            OR: 0.63 (0.41 to 0.97)                                                          
                                                                                                         Cohort studies:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                         41,214 pregnant women, 908 gestational hypertension                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SBP = Systolic blood pressure; DBP = Diastolic blood pressure.

nutrients-11-01362-t004_Table 4

###### 

Effect magnesium on blood pressure or association with hypertension risk: A summary of meta-analyses of randomized controlled trials and observational studies.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author-Year                                             No. of Trials   Study Characteristics                          No. Participants                              Study Aims                                                                                                                                                    Duration of Trials                  Magnesium Dosage (Diet or Supplement)                Blood Pressure Lowering in mmHg or RR (95% CI)                                                                                                                  Further Remarks/Summary
  ------------------------------------------------------- --------------- ---------------------------------------------- --------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------- ---------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------
  Zhang et al., 2016 \[[@B11-nutrients-11-01362]\]        27              Randomized controlled trials                   Magnesium group: 822\                         Effect of magnesium supplementation in normotensive and hypertensive adults (age 18--84 years).                                                               3 weeks--6 months                   Median dose of 368 mg/day (range: 238--960 mg/day)   SBP: −2 (−0.4 to −3.6)\                                                                                                                                         Magnesium supplementation at a median dose of 368 mg/day for a median duration of 3 months significantly reduced SBP and DBP.\
                                                                                                                         Placebo group: 800                                                                                                                                                                                                                                                                                   DBP: −1.8 (−0.7 to --2.8)                                                                                                                                       Magnesium supplementation at a dose of 300 mg/day or duration of 1 month is enough to elevate serum magnesium and reduce blood pressure.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Serum magnesium was negatively associated with DBP but not SBP.

  Dibaba et al., 2017 \[[@B48-nutrients-11-01362]\]       11              Randomized controlled trials                   543                                           Assessing the pooled effect of magnesium supplementation on blood pressure in participants with preclinical or non−communicable diseases.                     1 to 6 months (mean: 3.6 months)    365--450 mg/day                                      Standardized mean difference:\                                                                                                                                  Magnesium supplementation lowers blood pressure in individuals with insulin resistance, prediabetes, or other noncommunicable chronic diseases.
                                                                                                                                                                                                                                                                                                                                                                                                                              SBP: −0.2 (−0.4 to −0.03)\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                              DBP: −0.3 (−0.5 to −0.03)                                                                                                                                       

  Verma and Garg 2017 \[[@B49-nutrients-11-01362]\]       28              Randomized controlled trials                   1694 (834 treatment arm, 860 placebo arm)     Evaluation the effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors in both diabetic and nondiabetic individuals.\   4−24 weeks                          Elemental magnesium: 300--1006 mg/day                Weighted mean difference:\                                                                                                                                      A significant improvement was observed in SBP.\
                                                                                                                                                                       Only four studies were carried out in hypertensive subjects.                                                                                                                                                                                           SBP: −3.06 (−5.51 to −0.60)\                                                                                                                                    Insignificant improvement or no improvement was observed in DBP
                                                                                                                                                                                                                                                                                                                                                                                                                              DBP: −1.37 (−3.02 to 0.29)                                                                                                                                      

  Kass et al., 2012 \[[@B50-nutrients-11-01362]\]         22              Interventional studies                         1173                                          Assessing the effect of magnesium supplementation on blood pressure.\                                                                                         3 to 24 weeks of follow-up          Elemental magnesium dosage:\                         Overall effect size:\                                                                                                                                           Summary of all trials show a decrease in SBP of 3--4 mmHg and DBP of 2--3 mmHg.\
                                                                                                                                                                       Adults from 12 different countries were included.                                                                                                                                                 120--973 mg/day                                      SBP: 0.3 (0.2 to 0.4)\                                                                                                                                          Magnesium supplementation appears to achieve a small but clinically significant reduction in blood pressure.
                                                                                                                                                                                                                                                                                                                                                                                                                              DBP: 0.4 (0.3 to 0.4)                                                                                                                                           

  Rosanoff and Plesset\                                   7               Interventional studies                         135 treated hypertensive subjects             Evaluation of magnesium supplementation in hypertension.\                                                                                                     6 to 17 weeks                       10.5--18.5 mmol magnesium-salt/day                   Mean change:\                                                                                                                                                   This uniform subset of seven studies showed a strong effect of magnesium in treated hypertensive patients.
  2013 \[[@B51-nutrients-11-01362]\]                                                                                                                                   Initial SBP of the patients was \>155 mmHg                                                                                                                                                                                                             SBP: −18.7 (−22.5 to −15.0)\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                              DBP: −10.9 (−13.1 to −8.7)                                                                                                                                      

  **Observational studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Schoenaker et al., 2014 \[[@B45-nutrients-11-01362]\]   3               Observational studies                          6616 pregnant women, age range 20--40 years   Assessing the effect of dietary factors, including magnesium, on hypertensive disorders of pregnant women.                                                    NA                                  Not indicated                                        Significantly lower mean magnesium intake of mean 7.69 mg/day for women with hypertensive disorders of pregnancy (gestational hypertension and pre-eclampsia)   Pooled results revealed statistically significantly lower mean magnesium intake for women with hypertensive disorders of pregnancy.

  Han et al., 2017 \[[@B52-nutrients-11-01362]\]          10              Prospective cohort studies                     180,566 participates                          Assessing the relationship between dietary magnesium intake and serum magnesium concentrations on the risk of hypertension in adults.\                        4--15 years                         96--425 mg/day                                       RR: 0.95 (0.90 to 1.00) for a 100 mg/increment in magnesium intake.\                                                                                            Increase in magnesium intake was associated with a lower risk of hypertension in a linear dose-response pattern.
                                                                                                                                                                       Adult population \>18 years was included.                                                                                                                                                                                                              Comparing highest to lowest:\                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                              RR: 0.91 (0.80 to 1.02)                                                                                                                                         

  Wu J et al., 2017 \[[@B53-nutrients-11-01362]\]         3               Prospective cohort studies with four cohorts   14,876 participants (3149 cases)              Evaluation of circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus                               Average of 6.7 years of follow-up   NA                                                   Per 0.1 mmol/L increment in serum magnesium levels:\                                                                                                            A significant inverse linear association was observed between circulating magnesium levels and incidence of hypertension.
                                                                                                                                                                                                                                                                                                                                                                                                                              RR: 0.96 (0.93 to 0.99)                                                                                                                                         
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SBP = Systolic blood pressure; DBP = Diastolic blood pressure; NA = not applicable.
